Rich Duprey

Teaneck

It's faster horses, younger women, older whiskey, more money. Libertarian. Opinions are mine, but maybe don't be so freaking easily offended by everything.

Featured in: Favicon

msn.com

businessinsider.com (+1) Favicon

usatoday.com Favicon

aol.com

yahoo.com (+2) Favicon

freep.com

ibtimes.com Favicon

nasdaq.com Favicon

fool.com

foxbusiness.com + 114 more

Articles

Palantir Technologies Soars on New U.K. Trade Deal

1 week ago | moneymorning.com | Rich Duprey

Shares of Palantir Technologies (PLTR) jumped 8% on Thursday after President Trump announced a new trade deal with the U.K. The surge came as the market as a whole rose on the news with the Dow Jones Industrial Average and the S&P 500 both up 0.6%, but the Nasdaq 1%. All the indices gave back a little by the end of the trading day.
Pfizer (NYSE:PFE) Hasn't Been This Cheap in 13 Years. Time to Buy?

1 week ago | 247wallst.com | Rich Duprey

Investing Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the stock trades at its lowest levels in 13 years. Shares are down 19% over the past year and 63% from its December 2021 peak of $52.61 per share.
Palantir Technologies (NASDAQ: PLTR) Stock Price Prediction for 2025: Where Will It Be in 1 Year

1 week ago | 247wallst.com | Rich Duprey

Investing After reporting Q1 earnings on May 5, shares of Palantir Technologies (NASDAQ:PLTR) sold-off despite beating Wall Street’s estimates on the top and bottom lines and raising its full-year forecast. But on Thursday, it’s been a different story as the stock gained 8.22% through a.m. trading.
Down 30%, Is Starbucks Done?

1 week ago | 247wallst.com | Rich Duprey

Global coffee giant Starbucks (NASDAQ:SBUX) is finding itself in unfamiliar territory. With over 40,000 stores worldwide, it needs to navigate a turbulent market as it grapples with declining sales and customer goodwill. The java slinger has faced five consecutive quarters of falling same-store sales, including a 4% drop in the first quarter, driven by an 8% decline in U.S. transactions.
10 Stocks Reporting Earnings Today With Up To 74% Upside

1 week ago | 247wallst.com | Rich Duprey

Investing Earnings season is in full swing with hundreds of stocks scheduled to report results after the closing bell. The following 10 stocks are among the most anticipated companies releasing results after the market closes, with an average upside potential of 51.2%. Are you ahead, or behind on retirement?
5 Dividend ETFs to Buy and Hold for a Lifetime of Passive Income

1 week ago | 247wallst.com | Rich Duprey

Investing Dividend stock investing offers a reliable path to passive income and long-term wealth creation, making it a cornerstone for many portfolios. By owning shares in companies that pay regular dividends, investors gain consistent cash flow, often from stable, high-quality firms like Coca-Cola (NYSE:KO) or Johnson & Johnson (NYSE:JNJ).
Still the Best Coffee Stock to Buy? Dutch Bros Tops Estimates Again

1 week ago | moneymorning.com | Rich Duprey

Drive-thru coffee shop Dutch Bros (BROS) once again trounced Wall Street expectations, posting first-quarter earnings that handily beat analyst estimates on the top and bottom line. In a market where rival Starbucks (SBUX) and McDonald's (MCD) are disappointing investors, Dutch Bros continues to shine with higher sales and profits. By The NumbersThe third-largest coffee chain said revenue surged 29% to $355.2 million as comparable sales rose 4.7% from the year-ago period.
3 ETFs to Load Up On Before June for Explosive Growth

1 week ago | 247wallst.com | Rich Duprey

Investing Rallies, then sharp pullbacks seem to be the norm for the stock market these days. One step forward, two steps back. ETFs mitigate the risks associated with investing in individual securities because they diversify risk.
Hims & Hers Shows It's More Than Just GLP-1 Drugs

1 week ago | 247wallst.com | Rich Duprey

Hims & Hers Health (HIMS) released first-quarter earnings after the closing bell on Monday and saw shares surge on the robust numbers. HIMS stock jumped 18% on Tuesday after revenue doubled, profit surged, and new subscribers roared higher. Hims & Hers also signed a deal with Novo Nordisk (NVO) to sell its weight-loss drug Wegovy on the teleheath’s platform. Nvidia made early investors rich, but there is a new class of ‘Next Nvidia Stocks’ that could be even better.
ThredUp Surges 48% as New Shoppers Flood Thrift Market

1 week ago | moneymorning.com | Rich Duprey

Online resale shop ThredUp (TDUP) rocketed 48% higher yesterday after reporting record first-quarter results as tariffs caused shoppers to inundate the retailer. The number of new customers nearly doubled from the year before, rising 95% and continuing into the second quarter. ThredUp reported April was the strongest new customer acquisition month in the company's history.